Revenue: The sum of all revenue fields included for a company's operating activities.
International Stem Cell Corp. (ISCO) had Revenue of $9.09M for the most recently reported fiscal year, ending 2024-12-31.
Income Statement Financials | |
Revenue |
$9.09M |
$-0.21M |
|
$3.76M |
|
$5.32M |
|
$9.15M |
|
$-0.07M |
|
$-0.14M |
|
$-0.21M |
|
$-0.21M |
|
$-0.21M |
|
$-0.21M |
|
$-0.21M |
|
$-0.21M |
|
$-0.07M |
|
$0.14M |
|
8.00M |
|
8.00M |
|
$-0.03 |
|
$-0.03 |
|
Balance Sheet Financials | |
$3.56M |
|
$0.26M |
|
$1.61M |
|
$5.17M |
|
$4.69M |
|
-- |
|
$4.42M |
|
$9.10M |
|
$-3.94M |
|
$-4.65M |
|
$-3.93M |
|
8.00M |
|
Cash Flow Statement Financials | |
$0.01M |
|
$-0.17M |
|
$-0.20M |
|
$1.59M |
|
$1.23M |
|
$-0.36M |
|
$0.47M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
0.76 |
|
-- |
|
-- |
|
-- |
|
-- |
|
58.57% |
|
-0.75% |
|
-0.75% |
|
1.52% |
|
-2.30% |
|
-2.30% |
|
$-0.15M |
|
-- |
|
-- |
|
-- |
|
1.76 |
|
3.28 |
|
8.59 |
|
42.51 |
|
5.31% |
|
4.49% |
|
-4.04% |
|
5.32% |
|
$-0.49 |
|
$-0.02 |
|
$0.00 |